FactSet (FDS)
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-09-04
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-09-04
Warn: Primary pillar under pressure — Maintain Adjusted Operating Margin between 34.0% and 35.5% in FY 2026: FY26 guidance 34.0%-35.5% vs target 34.0%-35.5%.
FactSet grows revenue about 6% yearly to $2.46 billion in 2026. Organic subscription value rose $165 million, beating the $130M-$160M target. Profit margins stay near 34% despite some pressure. The company returns $629 million to shareholders in 2026.
Revenue growth may slow due to mixed guidance and analyst downgrades. Profit margins have declined from 36.8% to 34.0%. AI risks and market position concerns could hurt future results.
The price is about 6% below our fair value near $279, reflecting roughly 6% revenue growth. Our fair value is 13% above the Street median, which is more cautious. We see room for upside if growth and margins hold.
Breaks if: Capital returned falls below $629 million in fiscal YTD 2026
Continue strong capital return program including dividends and share repurchases, with $629 million returned fiscal YTD 2026.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on consistent revenue growth. The current thesis state is cautious, as recent performance has not met industry standards, and there are mixed signals from management priorities.
The market appears to be pricing in a durable premium, suggesting high expectations for FDS's performance. However, the current valuation is considered expensive compared to peers, indicating that investors may be anticipating strong future results.
Management has reaffirmed guidance for organic annual subscription value (ASV) growth and revenue, indicating a commitment to growth. However, there are concerns about margin compression and the potential for execution issues, which could impact future performance.
The long-term thesis hinges on the performance of sector bellwethers like SPGI, CME, and ICE. If these companies continue to perform well, it could provide a favorable backdrop for FDS. Conversely, any negative guidance or performance from these peers could pose risks to FDS's outlook.
The most important moves since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
Yes, our read has strengthened. The latest earnings beat supports a more favorable outlook. Additionally, the company is expected to increase Organic ASV by $130 million to $160 million in FY 2026. An analyst upgrade suggests a positive view on growth and performance.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. FactSet returned $243 million in Q3 2026 alone, totaling $629 million fiscal YTD through dividends and share repurchases. The capital return program is delivering strong execution with consistent quarterly deployment.
“Returned $243 million to shareholders in Q3, $629 million fiscal YTD.”
“Repurchased 651,750 shares for $163 million in Q2 2026.”
“Repurchased 478,100 shares for $139.9 million in Q1 2026.”
Breaks if: Operating margin falls below 34.0% in FY 2026
Improve adjusted operating margin to a range of 34.0% to 35.5% in fiscal year 2026.
Stated as a priority in 5 of last 5 quarters. Adjusted operating margin was 34.0% in 2026-Q2, down from 36.8% in 2025-Q3, with guidance reaffirmed at 34.0% to 35.5% for fiscal 2026. The trajectory shows margin compression relative to prior year but management maintains the target range.
“Adjusted operating margin expected in the range of 34.0% to 35.5% for fiscal 2026.”
“Adjusted operating margin is expected to be in the range of 34.0% to 35.5%.”
“FactSet reaffirms its outlook for fiscal 2026 adjusted operating margin.”
“Adjusted operating margin guidance reaffirmed at 34.0% to 35.5% for fiscal 2026.”
“Adjusted operating margin expected in the range of 34.0% to 35.5% for fiscal 2026.”
Breaks if: Organic ASV growth falls below $130M in FY 2026
Drive growth in Annual Subscription Value (ASV) organically by $130 million to $160 million during fiscal year 2026.
Stated as a priority in 5 of last 5 quarters. Organic ASV grew 7.1% or $165.0 million year over year to $2,485.6 million at 2026-Q3. Management reaffirmed fiscal 2026 guidance for organic ASV growth of $130 million to $160 million. The trajectory is delivering with consistent growth in organic ASV and reiterated guidance.
“Expected organic ASV growth of $130 million to $160 million during fiscal 2026.”
“Organic ASV is expected to grow in the range of $130 million to $160 million during fiscal 2026.”
“FactSet reaffirms its outlook for fiscal 2026, including organic ASV growth expectations.”
“Fiscal 2026 guidance updated with expected organic ASV growth of $130 million to $160 million.”
“Organic ASV is expected to grow in the range of $100 million to $150 million during fiscal 2026.”
Breaks if: Revenue falls below $2,450M in FY 2026
Grow GAAP revenues to a range of $2,450 million to $2,470 million in fiscal year 2026.
Stated as a priority in 5 of last 5 quarters. GAAP revenues grew from $2,321.7 million in fiscal 2025 to $622.9 million in Q3 2026 alone, with guidance reaffirmed for $2,450 million to $2,470 million in fiscal 2026. The trajectory is delivering consistent revenue growth and stable guidance.
“GAAP revenues expected in the range of $2,450 million to $2,470 million for fiscal 2026.”
“GAAP revenues are expected to be in the range of $2,450 million to $2,470 million.”
“FactSet reaffirms its outlook for fiscal 2026 with GAAP revenue guidance.”
“Fiscal 2026 guidance updated with GAAP revenues in the range of $2,450 million to $2,470 million.”
“GAAP revenues expected in the range of $2,423 million to $2,448 million for fiscal 2026.”
In the next 1 to 3 years, FDS's performance will depend on both its execution and the broader financial sector's health. The current situation suggests a need for careful monitoring. Not investment advice.